Abstract
Abstract The objective of the paper is to understand the impact of the COVID-19 focusing event that resulted in a distinctive response by the Federal government. The paper focuses on the rapid deregulation that occurred in the opioid use disorder treatments. We frame the narrative using primarily the economic literature on deregulation during a crisis. The temporary deregulation has significantly increased access to treatment and medications and allows for the discovering of a different equilibrium. We also suggest other deregulations that need to be considered. In this paper, we suggest that the provisional deregulations should be made permanent to improve the outcome of the patients who abuse opioids.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
